Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Ramat Gan, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Odysight.ai® Inc. (NASDAQ/TASE: ODYS), a leader in AI/ML-driven visual sensing solutions for predictive and conditions-based maintenance (CBM+),...
-
Malvern, Pennsylvania (USA), Jan. 02, 2025 (GLOBE NEWSWIRE) -- Rajant Corporation, the pioneer of Kinetic Mesh® wireless networks, and the US Army Combat Capabilities Development Command (DEVCOM)...
-
IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer
-
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel...
-
Agreement Focuses on Combining LIXTE’s LB-100 with Various Innovative Cancer Immunotherapies PASADENA, CA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and...
-
SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and...
-
CRADA will evaluate the immunogenicity and efficacy of two DNA-based Lassa virus vaccine candidates in animal models LAWRENCEVILLE, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:...
-
Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
-
WASHINGTON, May 10, 2022 (GLOBE NEWSWIRE) -- SAFCell Inc. has signed a Cooperative Research and Development Agreement (CRADA) with the Department of the Navy's U.S. Naval Research Laboratory (NRL). ...
-
Emily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator Boca Raton, FL, March 21, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the...